Shanghai China-norm Quality Technical Service Co., Ltd.
Shanghai, Shanghai Municipality, 200072, China
NCT Number: NCT06968416
65 female adult subjects will be enrolled in the study, recruited according to inclusion and non-inclusion criteria listed above. At least 40 subjects should complete the clinical evaluation and 60 subjects should complete consumer questionnaire in this 15-week study (wash-out phase for 3 weeks and treatment phase for 12 weeks). Subjects will need to refrain from using any product other than the provided test products on whole face including eye area during the 3-week wash-out phase and 12-week study treatment phase.
Looking for future studies?
Notify Me25 year–55 year
Female
Interventional
Not applicable
Shanghai, Shanghai Municipality, 200072, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Products Application and Usage Instruction
Frequency:
AM: Standard cleanser + standard moisturizer + standard sunscreen PM: Standard cleanser + standard moisturizer Caution: No any other skincare or facial make up products are used except provide products
Frequency:
AM: Standard cleanser + Investigational serum (face and eye) [FLA #774715 21] + standard moisturizer + standard sunscreen PM: Standard cleanser + Investigational serum (face and eye) [FLA #774715 21] + standard moisturizer
Caution: No any other skincare or facial make up products are used except provide products
Usage Instruction: Use serum [FLA #774715 21] 8-10 drops (0.3ml) on cleansed face and eye skin 2 times a day (AM & PM).
Time frame: Compare to baseline,Time point immediate , Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point immediate , Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point immediate , Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point immediate , Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point immediate , Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 1Week , Time point at 2Week, Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 4Week, Time point at 8Week and Time point at 12Week.
Time frame: Compare to baseline,Time point at 4Week, Time point at 8Week and Time point at 12Week.
ChinaNorm
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06657365
Anti-Aging, Facial Wrinkles
Beijing, China
View Trial DetailsNCT07565922
Anti-Aging, Hydration
Athens, Egaleo, Greece
View Trial DetailsNCT06613542
Aging, Biological, Anti-Aging
Munich, Germany
View Trial DetailsNCT06148558
Anti-Aging, Photoaging
Newtown Square, Pennsylvania, United States
View Trial Details